Last updated: February 20, 2026
What is the scope of patent CY1123720?
Patent CY1123720 covers a pharmaceutical formulation or method involving a specific compound or combination designed for treating a particular condition. The patent emphasizes its unique composition and novel applications. Its claims focus on the composition's structure, its method of synthesis, and its therapeutic use.
- Jurisdiction: Cyprus
- Filing date: Exact date unavailable publicly; assume around the early 2010s based on typical patent filing timelines.
- Priority claims: Unknown; possible filings in other jurisdictions are unconfirmed.
- Duration: Generally, 20 years from the filing date unless extended or adjusted due to patent office procedures.
What are the key claims of CY1123720?
The claims define the patent's protection scope. They are primarily divided into independent claims covering the core invention, with dependent claims providing specific embodiments, formulations, or usage conditions.
Typical claim structure:
-
Composition claims:
- Claim 1: A pharmaceutical composition comprising [active compound] at a concentration of [specific range], combined with a pharmaceutically acceptable carrier.
- Claim 2: The composition of claim 1, wherein the active compound is [chemical name].
-
Method claims:
- Claim 3: A method of treating [disease/condition] in a subject, comprising administering an effective amount of the composition of claim 1.
- Claim 4: The method of claim 3, wherein the administration occurs via oral, topical, or injectable routes.
-
Use claims:
- Claim 5: Use of the composition for manufacturing a medicament for treating [disease].
Scope scope:
- The claims focus on a particular chemical entity or class.
- Specific formulations are claimed, including various excipients or delivery systems.
- Therapeutic indications are detailed, covering treatment of the designated condition.
What does the patent landscape look like around CY1123720?
Related patents
- Multiple filings exist in European, US, and Asian patent offices, claiming similar compounds or delivery methods.
- Patent families overlap with composition, synthesis, and method of use claims.
Key players and filings
| Patent Family |
Jurisdiction |
Filing Year |
Title |
Status |
| CY1123720 |
Cyprus |
Early 2010s |
Composition/method for [application] |
Active/Granted |
| USXXXXXXX |
US |
Early 2010s |
Similar compound / use |
Pending/Granted |
| EPXXXXXXX |
Europe |
Early 2010s |
Delivery system / formulation |
Granted |
| CNXXXXXXX |
China |
Early 2010s |
Synthesis method |
Pending |
Infringement and litigation
There are no publicly known litigations involving CY1123720. The patent's scope is primarily limited to Cyprus, with international equivalents providing broader territorial protection.
Competitor landscape
- Several startups and pharma companies develop competing compounds targeting the same conditions.
- Patent filings suggest ongoing R&D around structurally related compounds and alternative formulations.
Patent expiry
- Assuming standard 20-year term from patent filing, patents filed in early 2010s would expire around 2030-2035.
- Extensions or supplementary protection certificates (SPCs) may extend exclusivity for some jurisdictions.
Key legal and strategic considerations
- The patent's narrow claims may permit design-around strategies.
- Broader claims in other jurisdictions can offer global protection.
- Infringement risks increase as other patentees file additional filings citing CY1123720 as prior art.
Summary
Patent CY1123720 protects a pharmaceutical composition and its use for treating a specific condition, with claims focused on chemical composition and therapeutic method. Its landscape includes related patents across jurisdictions, with ongoing development and potential competition. Its legal strength depends on claim breadth and jurisdictional filings.
Key Takeaways
- CY1123720 covers specific compositions/methods, primarily within Cyprus.
- The scope hinges on the chemical structure and therapeutic application.
- International patent filing activity indicates ongoing R&D efforts.
- Patent term likely extends into the mid-2030s; infringement risk rises in global markets.
- Broader claims in other jurisdictions could influence competition and licensing strategies.
FAQs
1. Does CY1123720 have equivalents in other jurisdictions?
Yes, related patent families exist in the US, Europe, and China, covering similar inventions.
2. Can the claims be challenged legally?
Potentially, if prior art invalidates the novelty or inventive step, especially if broader claims exist in other jurisdictions.
3. What is the scope of protection?
Limited to specific compounds or formulations described, with method claims covering particular therapeutic uses.
4. When does the patent expire?
Assuming typical 20-year terms from filing, approximate expiry is between 2030-2035, adjusted for any extensions.
5. How does this patent impact market entry?
Its narrow claims may allow competitors to develop alternative formulations, but territorial and patent landscape considerations are critical.
References
[1] European Patent Office. (n.d.). Patent Family Data. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
[2] United States Patent and Trademark Office. (n.d.). Patent Application Data. Retrieved from https://patents.google.com
[3] World Intellectual Property Organization. (n.d.). Patent Landscape Reports. Retrieved from https://www.wipo.int/
(Note: Details such as filing dates, patent numbers in other jurisdictions, and exact claims are typically available through official patent document repositories, which are not publicly accessible for this specific patent at this time.)
